Oxidative stress and human genetic variation

Journal of Nutrition

Volumn 134, Issue 11, 2004, Pages

  Morgenstern, Ralf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Genetic variation; Oxidative stress; Polymorphisms

Indexed keywords

ARYLDIALKYLPHOSPHATASE; DNA; GLUTATHIONE TRANSFERASE; HEME OXYGENASE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

CONFERENCE PAPER; DNA BINDING; EPIDEMIOLOGICAL DATA; GENE DELETION; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; LIPID METABOLISM; OXIDATIVE STRESS; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 7944225561     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.11.3173s     Document Type: Conference Paper

References (16)

1. Forsberg, L, de Faire, U. & Morgenstern, R. (2001) Oxidative stress, human genetic variation, and disease. Arch. Biochem. Biophys. 389: 84-93.
2. Emahazion, T., Feuk, L., Jobs, M., Sawyer, S. L., Fredman, D., St. Clair, D., Prince, J. A. & Brookes, A. J. (2001) SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet. 17: 407-413.
3. Seidegard, J., Pero, R. W., Miller, D. G. & Beattie, E. J. (1986) A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 7: 751-753.
4. Benhamou, S., Lee, W. J., Alexandrie, A. K., Boffetta, P., Bouchardy, C., Butkiewicz, D., Brockmoller, J., Clapper, M. L., Daly, A. et al. (2002) Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23: 1343-1350.
5. Hemminki, K., Lonnstedt, I., Vaittinen, P. & Lichtenstein, P. (2001) Estimation of genetic and environmental components in colorectal and lung cancer and melanoma. Genet. Epidemiol. 20: 107-116.
6. Czene, K., Lichtenstein, P. & Hemminki, K. (2002) Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database, Int. J. Cancer 99: 260-266.
7. Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. & Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343: 78-85.
8. Neumann, C. A., Krause, D. S., Carman, C. V., Das, S., Dubey, D. P., Abraham, J. L., Bronson, R. T., Fujiwara, Y., Orkin, S. H. et al. (2003) Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression, Nature 424: 561-565.
9. Hayes, J. D. & Strange, R. C. (2002) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61: 154-166.
10. Morgan, G. J. & Smith, M. T. (2002) Metabolic enzyme polymorphisms and susceptibility to acute leukemia in adults. Am. J. Pharmacogenomics 2: 79-92.
11. Park, S.-J., Zhao, H., Spitz, M. R.,Grossman, H. B. & Wu, X. (2003) An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutation Res. 536: 131-137.
12. Stoehlmacher, J., Ingles, S. A., Park, D. J., Zhang, W. & Lenz, H.-J. (2002) The -9Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese Superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma. Oncol. Rep. 9: 235-238.
13. Ambrosone, C. B., Freudenheim, J. L., Thompson, P. A., Bowman, E., Vena, J. E., Marshall, J. E., Graham, S., Laughlin, R., Nemoto, T. & Shields, P. G. (1999) Manganese Superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 59: 602-606.
14. Marchand, L. L., Donlon, T., Lum-Jones, A., Seifried, A. & Wilkens, L. R. (2002) Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol. Biomark. Prev. 11: 409-412.
15. Schabath, M. B., Spitz, M. R., Delclos, G. L., Gunn, G. B., Whitehead, L. W. & Wu, X. (2002) Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am. J. Ind. Med. 42: 29-37.
16. Suzuki, T., Nakagawa, T., Endo, H., Mitsudomi, T., Masada, A., Yatabe, Y., Suguira, T., Takahashi, T. & Hida, T. (2002) The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 ('Iressa') is not related to the expression of EGFR or HER-2 or to K-ras gene status. Lung Cancer 37: 35-41.